Literature DB >> 11293444

Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis.

I Colle1, R Moreau, F Pessione, E Rassiat, J Heller, C Chagneau, D Pateron, E Barrière, B Condat, P Sogni, D Valla, D Lebrec.   

Abstract

OBJECTIVE: In patients with cirrhosis, the relationships between haemodynamic alterations and the development of ascites or the occurrence of refractory ascites are unknown. The aim of the present study was to compare haemodynamic measurements obtained in patients with non-refractory ascites to haemodynamic measurements obtained in patients without ascites and in patients with refractory ascites.
METHODS: A cohort of 121 patients was prospectively studied, of whom 29 patients did not have ascites, 45 had non-refractory ascites and 47 had refractory ascites. Splanchnic, renal and systemic haemodynamics were measured in all patients.
RESULTS: The hepatic venous pressure gradient was significantly higher in patients with non-refractory ascites than in patients without ascites (18.5 +/- 0.8 mmHg versus 15.8 +/- 0.7 mmHg). Renal and systemic haemodynamics did not significantly differ between patients with non-refractory ascites and patients without ascites. The glomerular filtration rate and renal blood flow were significantly lower in patients with refractory ascites than in patients with non-refractory ascites (77 +/- 4 versus 107 +/- 5 ml/min and 867 +/- 62 versus 1,008 +/- 68 ml/min, respectively). Splanchnic and systemic haemodynamics did not significantly differ between patients with refractory ascites and patients with non-refractory ascites.
CONCLUSIONS: In patients with cirrhosis, an increase in portal hypertension was the sole haemodynamic alteration related to the development of ascites. Renal vasoconstriction (and subsequent renal hypoperfusion and hypofiltration) was the only haemodynamic alteration related to the occurrence of refractory ascites. The development of ascites or refractory ascites was not associated with any alteration in systemic haemodynamics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11293444     DOI: 10.1097/00042737-200103000-00006

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  Hyperreninemic hypoaldosteronism syndrome, plasma concentrations of interleukin-6 and outcome in critically ill patients with liver cirrhosis.

Authors:  Damien du Cheyron; Bruno Bouchet; Brigitte Cauquelin; Damien Guillotin; Michel Ramakers; Cédric Daubin; Jean-Jacques Ballet; Pierre Charbonneau
Journal:  Intensive Care Med       Date:  2007-09-29       Impact factor: 17.440

2.  Impact of Propranolol on Preventing Renal Dysfunction in Patients with Cirrhosis.

Authors:  Kambiz Akhavan Rezayat; Abbas Ali Zeraati; Masoud Pezeshki Rad; Jalal Chogan; Najmeh Davoudian; Amir Akhavan Rezayat; Seyed Mousalreza Hoseini
Journal:  Middle East J Dig Dis       Date:  2017-10

Review 3.  Optimal management of hepatorenal syndrome in patients with cirrhosis.

Authors:  Paolo Angeli; Filippo Morando
Journal:  Hepat Med       Date:  2010-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.